Chimeric antigen receptor T-cell therapy outcomes in T cell/histiocyte-rich large B-cell lymphoma and subsequent treatment strategies after disease progression: A GELTAMO/GETH study

IACOBONI, GLORIA; CABALLERO GONZÁLEZ, ANA CAROLINA; Delgado Serrano, Javier; BASTOS, MARIANA; Martínez-Cibrian, Nuria; Barba, Pere; Navarro Garces, Victor

Ver

Chimeric antigen receptor T-cell therapy outcomes in T cell/histiocyte-rich large B-cell lymphoma and subsequent treatment strategies after disease progression: A GELTAMO/GETH study, 2025 (393.1Kb)

Autor

IACOBONI, GLORIA

CABALLERO GONZÁLEZ, ANA CAROLINA

Delgado Serrano, Javier

BASTOS, MARIANA

Martínez-Cibrian, Nuria

Barba, Pere

Navarro Garces, Victor

Fecha

2025-02-04

Enlace permanente

http://hdl.handle.net/11351/12787

DOI

10.1002/hem3.70077

ISSN

2572-9241

WOS

001413884400001

PMID

39906687

Registro Completo

Palabras clave

Terapia de células T; Linfoma de células B grandes; Progresión de la enfermedad

Citación recomendada

Bastos-Oreiro M, Iacoboni G, Garcés VN, Caballero AC, Martínez N, Delgado J, et al. Chimeric antigen receptor T-cell therapy outcomes in T cell/histiocyte-rich large B-cell lymphoma and subsequent treatment strategies after disease progression: A GELTAMO/GETH study. HemaSphere. 2025 Feb;9(2):e70077.